In the present study, we established an early-onset T1DM mouse model by post-fasting injection of STZ in week 3 at two different doses, 40 and 80 mg/kg, leading to two different levels of blood glucose, HbA1c, insulin, and body weight gain in diabetic animals (Figure 1A-C and F). Here, INS is linked to type 1 diabetes mellitus.